Page last updated: 2024-10-26

eicosapentaenoic acid ethyl ester and Cerebral Infarction

eicosapentaenoic acid ethyl ester has been researched along with Cerebral Infarction in 1 studies

Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Katsumata, T1
Katayama, Y1
Obo, R1
Muramatsu, H1
Ohtori, T1
Terashi, A1

Other Studies

1 other study available for eicosapentaenoic acid ethyl ester and Cerebral Infarction

ArticleYear
Delayed administration of ethyl eicosapentate improves local cerebral blood flow and metabolism without affecting infarct volumes in the rat focal ischemic model.
    European journal of pharmacology, 1999, May-14, Volume: 372, Issue:2

    Topics: Animals; Autoradiography; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; Delayed-

1999